Laboratorios Farmaceuticos ROVI

Laboratorios Farmaceuticos ROVI Intangible Assets

The Intangible Assets of Laboratorios Farmaceuticos ROVI (ROVI.MC) as of Oct 10, 2026 is 33.95 M EUR. In the previous year, Intangible Assets was 33.90 M EUR — a change of 0.14% (higher).

Intangible Assets

33.95 MEUR

YoY

0.14%

Last updated:

Intangible Assets of Laboratorios Farmaceuticos ROVI is 2024 33.95 M EUR. Intangible Assets of Laboratorios Farmaceuticos ROVI was 2023 33.90 M EUR. It decreases by 0.14% higher compared to the previous year.

The Laboratorios Farmaceuticos ROVI Intangible Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Intangible Assets
Date
Intangible Assets
Jan 1, 2017
27.08 M EUR
Jan 1, 2018
34.65 M EUR
Jan 1, 2019
45.08 M EUR
Jan 1, 2020
41.41 M EUR
Jan 1, 2021
38.56 M EUR
Jan 1, 2022
35.74 M EUR
Jan 1, 2023
33.90 M EUR
Jan 1, 2024
33.95 M EUR
The Laboratorios Farmaceuticos ROVI Intangible Assets history
YEARIntangible AssetsYoY
33.95 MEUR+0.14%
33.90 MEUR-5.15%
35.74 MEUR-7.30%
38.56 MEUR-6.89%
41.41 MEUR-8.13%
45.08 MEUR+30.10%
34.65 MEUR+27.96%
27.08 MEUR+8.87%
24.87 MEUR+31.73%
18.88 MEUR+9.73%
17.21 MEUR—
Access this data via the Eulerpool API

Laboratorios Farmaceuticos ROVI Stock analysis

What does Laboratorios Farmaceuticos ROVI do? Laboratorios Farmaceuticos ROVI SA is a Spanish pharmaceutical company that was founded in 1946 by Salvador and Ignacio Ruiz-Salmones. The company is headquartered in Madrid and employs over 1,000 employees. ROVI manufactures a variety of pharmaceutical products and offers services in various areas. The company specializes in the development and manufacturing of specialty preparations in the fields of oncology, hematology, endocrinology, and gastroenterology. The company operates in three business areas: specialty pharmaceuticals, contrast agents, and active ingredients for the industry. The specialty pharmaceuticals business area includes medications for various applications, such as the treatment of cancer, blood disorders, endocrine disorders, gastroenterological disorders, and central nervous system disorders. The contrast agents division produces products for radiology and diagnostics. The products are used in various medical fields, from cardiology to gastroenterology. In the active ingredients for the industry business area, ROVI manufactures active ingredients for other pharmaceutical companies. ROVI specializes in the production of specialty products and relies on collaborations with other companies. The company has strategic partnerships with many companies such as GlaxoSmithKline, Pfizer, Sanofi-Aventis, and Zeltia. This also includes some research collaborations to develop and market products together. The company is also dedicated to the development of biosimilars, which allow for the offering of biologic drugs at a lower price. Biosimilars are copies of biopharmaceuticals that are usually very expensive due to the complex manufacturing process and high development costs. ROVI is also a major producer of vaccines that are distributed worldwide. ROVI has followed a solid growth trajectory in recent years. The company has been able to consistently increase its revenue and profit and is now a major player in the pharmaceutical industry. The company also operates a strong research and development department that constantly develops new products and technologies to improve patient care. In summary, Laboratorios Farmaceuticos ROVI SA is a leading pharmaceutical company specializing in the manufacturing of specialty products. With its subsidiaries in Europe and the USA, ROVI has an international presence and has made a name for itself through its expertise in the development and manufacturing of innovative pharmaceutical products. Laboratorios Farmaceuticos ROVI is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Laboratorios Farmaceuticos ROVI stock

Intangible Assets of Laboratorios Farmaceuticos ROVI is 33.95 M EUR in 2024.

Intangible Assets of Laboratorios Farmaceuticos ROVI changed from 33.90 M EUR to 33.95 M EUR, representing a 0.14% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Intangible Assets Laboratorios Farmaceuticos ROVI since 2006 – with annual values, charts, and detailed analysis.

Intangible assets are non-physical assets such as patents, trademarks, copyrights, and software. They can be significant value drivers for technology and pharmaceutical companies.

Intangible Assets's EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Intangible Assets's Laboratorios Farmaceuticos ROVI historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Laboratorios Farmaceuticos ROVI

All Key Metrics — Laboratorios Farmaceuticos ROVI